A novel histone deacetylase inhibitor exerts promising anti-breast cancer activity via triggering AIFM1-dependent programmed necrosis
Corresponding Author
Peipei Shan
Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, Shandong, 266021 P. R. China
Correspondence
Peipei Shan, Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University. Qingdao 266021, P. R. China
Email: [email protected]
Sujie Zhu, Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University. Qingdao 266021, P. R. China.
Email: [email protected]
Hua Zhang, School of Biological Science and Technology, University of Jinan, Jinan 250022, P. R. China.
Email: [email protected]
Search for more papers by this authorFeifei Yang
School of Biological Science and Technology, University of Jinan, Jinan, Shandong, 250022 P. R. China
Search for more papers by this authorJie Yu
Qingdao Center Hospital: Qingdao Center Medical Group, Qingdao, Shandong, 266042 P. R. China
Search for more papers by this authorLirong Wang
Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, Shandong, 266021 P. R. China
Search for more papers by this authorYuhua Qu
School of Biological Science and Technology, University of Jinan, Jinan, Shandong, 250022 P. R. China
Search for more papers by this authorHuiran Qiu
School of Biological Science and Technology, University of Jinan, Jinan, Shandong, 250022 P. R. China
Search for more papers by this authorCorresponding Author
Hua Zhang
School of Biological Science and Technology, University of Jinan, Jinan, Shandong, 250022 P. R. China
Correspondence
Peipei Shan, Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University. Qingdao 266021, P. R. China
Email: [email protected]
Sujie Zhu, Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University. Qingdao 266021, P. R. China.
Email: [email protected]
Hua Zhang, School of Biological Science and Technology, University of Jinan, Jinan 250022, P. R. China.
Email: [email protected]
Search for more papers by this authorCorresponding Author
Sujie Zhu
Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, Shandong, 266021 P. R. China
Correspondence
Peipei Shan, Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University. Qingdao 266021, P. R. China
Email: [email protected]
Sujie Zhu, Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University. Qingdao 266021, P. R. China.
Email: [email protected]
Hua Zhang, School of Biological Science and Technology, University of Jinan, Jinan 250022, P. R. China.
Email: [email protected]
Search for more papers by this authorCorresponding Author
Peipei Shan
Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, Shandong, 266021 P. R. China
Correspondence
Peipei Shan, Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University. Qingdao 266021, P. R. China
Email: [email protected]
Sujie Zhu, Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University. Qingdao 266021, P. R. China.
Email: [email protected]
Hua Zhang, School of Biological Science and Technology, University of Jinan, Jinan 250022, P. R. China.
Email: [email protected]
Search for more papers by this authorFeifei Yang
School of Biological Science and Technology, University of Jinan, Jinan, Shandong, 250022 P. R. China
Search for more papers by this authorJie Yu
Qingdao Center Hospital: Qingdao Center Medical Group, Qingdao, Shandong, 266042 P. R. China
Search for more papers by this authorLirong Wang
Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, Shandong, 266021 P. R. China
Search for more papers by this authorYuhua Qu
School of Biological Science and Technology, University of Jinan, Jinan, Shandong, 250022 P. R. China
Search for more papers by this authorHuiran Qiu
School of Biological Science and Technology, University of Jinan, Jinan, Shandong, 250022 P. R. China
Search for more papers by this authorCorresponding Author
Hua Zhang
School of Biological Science and Technology, University of Jinan, Jinan, Shandong, 250022 P. R. China
Correspondence
Peipei Shan, Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University. Qingdao 266021, P. R. China
Email: [email protected]
Sujie Zhu, Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University. Qingdao 266021, P. R. China.
Email: [email protected]
Hua Zhang, School of Biological Science and Technology, University of Jinan, Jinan 250022, P. R. China.
Email: [email protected]
Search for more papers by this authorCorresponding Author
Sujie Zhu
Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, Shandong, 266021 P. R. China
Correspondence
Peipei Shan, Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University. Qingdao 266021, P. R. China
Email: [email protected]
Sujie Zhu, Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University. Qingdao 266021, P. R. China.
Email: [email protected]
Hua Zhang, School of Biological Science and Technology, University of Jinan, Jinan 250022, P. R. China.
Email: [email protected]
Search for more papers by this authorPeipei Shan and Feifei Yang contributed equally to this work.
Supporting Information
| Filename | Description |
|---|---|
| cac212362-sup-0001-SuppMat.docx1.8 MB | Supporting information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Cesca MG, Vian L, Cristovao-Ferreira S, Ponde N, de Azambuja E. HER2-positive advanced breast cancer treatment in 2020. Cancer Treat Rev. 2020; 88:102033.
- 2Huang M, Zhang J, Yan C, Li X, Zhang J, Ling R. Small molecule HDAC inhibitors: Promising agents for breast cancer treatment. Bioorg Chem. 2019; 91:103184.
- 3Khan O, La Thangue NB. HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications. Immunol Cell Biol. 2012; 90(1): 85–94.
- 4Qiu T, Zhou L, Zhu W, Wang T, Wang J, Shu Y, et al. Effects of treatment with histone deacetylase inhibitors in solid tumors: a review based on 30 clinical trials. Future Oncol. 2013; 9(2): 255–69.
- 5Somech R, Izraeli S, A JS. Histone deacetylase inhibitors–a new tool to treat cancer. Cancer Treat Rev. 2004; 30(5): 461–72.
- 6Mann BS, Johnson JR, Cohen MH, Justice R, Pazdur R. FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. Oncologist. 2007; 12(10): 1247–52.
- 7Minsart C, Liefferinckx C, Lemmers A, Dressen C, Quertinmont E, Leclercq I, et al. New insights in acetaminophen toxicity: HMGB1 contributes by itself to amplify hepatocyte necrosis in vitro through the TLR4-TRIF-RIPK3 axis. Sci Rep. 2020; 10(1): 5557.
- 8Artus C, Boujrad H, Bouharrour A, Brunelle MN, Hoos S, Yuste VJ, et al. AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX. EMBO J. 2010; 29(9): 1585–99.
- 9Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CY, et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature. 2001; 410(6828): 549–54.
- 10Burton TR, Eisenstat DD, Gibson SB. BNIP3 (Bcl-2 19 kDa interacting protein) acts as transcriptional repressor of apoptosis-inducing factor expression preventing cell death in human malignant gliomas. J Neurosci. 2009; 29(13): 4189–99.
